73 related articles for article (PubMed ID: 16424055)
21. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
22. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
[TBL] [Abstract][Full Text] [Related]
23. Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.
Chen Y; Emtage P; Zhu Q; Foley R; Muller W; Hitt M; Gauldie J; Wan Y
Gene Ther; 2001 Feb; 8(4):316-23. PubMed ID: 11313806
[TBL] [Abstract][Full Text] [Related]
24. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.
Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Miyagi T; Jinushi M; Sakamori R; Kohga K; Uemura A; Ohkawa K; Storkus WJ; Hayashi N
Gene Ther; 2007 Jun; 14(11):863-71. PubMed ID: 17344900
[TBL] [Abstract][Full Text] [Related]
25. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z
Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993
[TBL] [Abstract][Full Text] [Related]
26. The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells.
Mackenzie-Dyck S; Attah-Poku S; Juillard V; Babiuk LA; van Drunen Littel-van den Hurk S
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):87-107. PubMed ID: 21764462
[TBL] [Abstract][Full Text] [Related]
27. Murine splenic CD4⁺ T cells, induced by innate immune cell interactions and secreted factors, develop antileukemia cytotoxicity.
Nelles ME; Moreau JM; Furlonger CL; Berger A; Medin JA; Paige CJ
Cancer Immunol Res; 2014 Nov; 2(11):1113-24. PubMed ID: 25154710
[TBL] [Abstract][Full Text] [Related]
28. Antitumor immunity induced by irradiated tumor cells producing macrophage colony-stimulating factor.
Suzu S; Kimura F; Tanaka-Douzono M; Yamada M; Nakamura Y; Wakimoto N; Sato K; Morita T; Ikeda K; Motoyoshi K
Int J Hematol; 2001 Apr; 73(3):378-82. PubMed ID: 11345206
[TBL] [Abstract][Full Text] [Related]
29. Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells.
Zhang B; Wu KF; Lin YM; Ma XT; Rao Q; Zheng GG; Cao ZY; Li G; Song YH
Leukemia; 2004 Apr; 18(4):817-25. PubMed ID: 14990975
[TBL] [Abstract][Full Text] [Related]
30. Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia.
Conrad DP; Tsang J; Maclean M; Diallo JS; Le Boeuf F; Lemay CG; Falls TJ; Parato KA; Bell JC; Atkins HL
Clin Cancer Res; 2013 Jul; 19(14):3832-43. PubMed ID: 23714728
[TBL] [Abstract][Full Text] [Related]
31. Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity.
Dunussi-Joannopoulos K; Runyon K; Erickson J; Schaub RG; Hawley RG; Leonard JP
Blood; 1999 Dec; 94(12):4263-73. PubMed ID: 10590071
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of mesenchymal stem cells carrying murine beta defensin 2 on malignant ascites in mice].
Wang GQ; Xu JR; Wang R; Li HX; Xu N; Du XB; Wei YQ
Ai Zheng; 2006 Jun; 25(6):657-62. PubMed ID: 16764757
[TBL] [Abstract][Full Text] [Related]
33. Expression of beta defensin 2 in experimental pulmonary tuberculosis: tentative approach for vaccine development.
Rivas-Santiago B; Cervantes-Villagrana A; Sada E; Hernández-Pando R
Arch Med Res; 2012 May; 43(4):324-8. PubMed ID: 22705089
[TBL] [Abstract][Full Text] [Related]
34. An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment.
Gibbins JD; Ancelet LR; Weinkove R; Compton BJ; Painter GF; Petersen TR; Hermans IF
Blood; 2014 Nov; 124(19):2953-63. PubMed ID: 25237205
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporin A/VP-16 produced immunity to L1210 leukemia: the participation of cytotoxic CD8 T-lymphocytes.
Slater LM; Sweet P; Stupecky M; Reynolds JT
Clin Immunol Immunopathol; 1995 Jun; 75(3):239-45. PubMed ID: 7768041
[TBL] [Abstract][Full Text] [Related]
36. Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6.
Taylor K; Rolfe M; Reynolds N; Kilanowski F; Pathania U; Clarke D; Yang D; Oppenheim J; Samuel K; Howie S; Barran P; Macmillan D; Campopiano D; Dorin J
Eur J Immunol; 2009 May; 39(5):1353-60. PubMed ID: 19404978
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole.
Kataoka T; Tsukagoshi S; Sakurai Y; Okabe M
Gan; 1979 Aug; 70(4):515-9. PubMed ID: 510850
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor angiogenesis effect of genetic fusion vaccine encoding murine beta-defensin 2 and tumor endothelial marker-8 in a CT-26 murine colorectal carcinoma model.
Liu P; Xie G; Geng P; Zheng C; Li J; Pan F; Ruan Z; Liang H
Int J Clin Exp Med; 2015; 8(3):4744-52. PubMed ID: 26064415
[TBL] [Abstract][Full Text] [Related]
39. A Personalized Cancer Vaccine that Induces Synergistic Innate and Adaptive Immune Responses.
Kuen DS; Hong J; Lee S; Koh CH; Kwak M; Kim BS; Jung M; Kim YJ; Cho BS; Kim BS; Chung Y
Adv Mater; 2023 Sep; 35(36):e2303080. PubMed ID: 37249019
[TBL] [Abstract][Full Text] [Related]
40. Chitin oligomers promote lymphoid innate and adaptive immune cell activation.
Maia A; Cardona Gloria Y; Fuchs K; Chang TH; Engels P; Zhou M; Hinnenthal T; Rusch E; Gouttefangeas C; Weber ANR
J Leukoc Biol; 2023 Jul; 114(2):180-186. PubMed ID: 37075217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
